Brief: Alphamab Oncology Says CEO Buys 554,000 Shares On June 4
05/06/2026 02:24
BRIEF-Alphamab Oncology Says CEO Buys 554,000 Shares On June 4 June 5 (Reuters) - Alphamab Oncology 9966.HK:
CEO DR. XU TING PURCHASES 554,000 SHARES ON OPEN MARKET ON JUNE 4, 2026
AGGREGATE CONSIDERATION FOR SHARE PURCHASES TOTALS HK$4.99 MILLION AT HK$7.375 PER SHARE
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)